The analysis of 396 TCGA (The Cancer Genome Atlas) BC cases examined under PAM50 standards, a prediction test routinely performed following biopsy or surgery, further supports these clinical observations by confirming the negative correlation between HLA-A expression, IFN signaling (a master inducer of MHC I expression), and ER activity. This evidence concerns the gene HLA-A and breast cancer.